Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
PETER R MCNALLY
Listed Specialty: Gastroenterology
EVANS ARMY COMMUNITY HOSPITAL, GI CLINIC, FT CARSON, CO, 80913-4604
Is this you? Do you believe the data contains errors? Click here for information →
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
DR. PETER MCNALLY,
Yearly Payment Breakdown:
2018 Payments At a Glance
174
payments
$245,691
payment total
7
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
| Category | Payments | Payment Value |
|---|---|---|
Promotional Speaking/Other |
51 | $163K |
Honoraria |
12 | $46,800 |
Travel and Lodging |
92 | $32,684 |
Food and Beverage |
18 | $1,494 |
Consulting |
1 | $1,400 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
| Product Name | Product Type | Payments† |
|---|---|---|
STELARA |
drug |
$53,718 |
PRIMARY CARE - DISEASE STATE |
drug |
$51,375 |
REMICADE |
drug |
$48,781 |
ENTYVIO |
drug |
$48,049 |
Payments with no listed product |
N/A |
$31,980 |
HUMIRA |
drug |
$24,069 |
XELJANZ |
drug |
$14,666 |
EPCLUSA |
drug |
$11,946 |
INFLECTRA |
drug |
$9,888 |
SIMPONI |
drug |
$16 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
Payment Details in 2018
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| Aug 14, 2018 | $8,048 | ENTYVIO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Apr 5, 2018 | $8,048 | ENTYVIO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Sep 26, 2018 | $8,048 | ENTYVIO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Mar 8, 2018 | $8,048 | ENTYVIO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Nov 19, 2018 | $5,200 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| Dec 3, 2018 | $5,200 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| Oct 10, 2018 | $5,200 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| Sep 24, 2018 | $5,200 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| May 2, 2018 | $5,200 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| Jun 19, 2018 | $5,200 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| Oct 11, 2018 | $4,163 | ENTYVIO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Aug 30, 2018 | $4,163 | ENTYVIO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Dec 18, 2018 | $3,750 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Dec 18, 2018 | $3,750 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| May 1, 2018 | $3,500 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Oct 9, 2018 | $3,500 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Feb 18, 2018 | $3,500 | STELARA | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| May 8, 2018 | $3,500 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Sep 25, 2018 | $3,500 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Jun 26, 2018 | $3,500 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Nov 15, 2018 | $3,500 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Jun 11, 2018 | $3,500 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Apr 4, 2018 | $3,150 | HUMIRA | Promotional Speaking/Other | ABBVIE, INC. | |
| Mar 13, 2018 | $3,150 | HUMIRA | Promotional Speaking/Other | ABBVIE, INC. | |
| Feb 6, 2018 | $3,150 | No Listed Product | Promotional Speaking/Other | ABBVIE, INC. | |
| Mar 13, 2018 | $3,150 | HUMIRA | Promotional Speaking/Other | ABBVIE, INC. | |
| Apr 17, 2018 | $3,150 | HUMIRA | Promotional Speaking/Other | ABBVIE, INC. | |
| Apr 17, 2018 | $3,150 | No Listed Product | Promotional Speaking/Other | ABBVIE, INC. | |
| Sep 20, 2018 | $3,150 | HUMIRA | Promotional Speaking/Other | ABBVIE, INC. | |
| Sep 5, 2018 | $3,150 | No Listed Product | Promotional Speaking/Other | ABBVIE, INC. | |
| Apr 3, 2018 | $3,150 | No Listed Product | Promotional Speaking/Other | ABBVIE, INC. | |
| Sep 5, 2018 | $3,150 | HUMIRA | Promotional Speaking/Other | ABBVIE, INC. | |
| Apr 24, 2018 | $3,150 | No Listed Product | Promotional Speaking/Other | ABBVIE, INC. | |
| May 16, 2018 | $3,150 | No Listed Product | Promotional Speaking/Other | ABBVIE, INC. | |
| Jun 2, 2018 | $3,000 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Sep 11, 2018 | $2,750 | INFLECTRA | Promotional Speaking/Other | PFIZER INC. | |
| Jul 16, 2018 | $2,750 | No Listed Product | Promotional Speaking/Other | PFIZER INC. | |
| Dec 7, 2018 | $2,750 | XELJANZ | Promotional Speaking/Other | PFIZER INC. | |
| Jan 8, 2018 | $2,750 | INFLECTRA | Promotional Speaking/Other | PFIZER INC. | |
| Jul 16, 2018 | $2,750 | No Listed Product | Promotional Speaking/Other | PFIZER INC. | |
| May 22, 2018 | $2,600 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| Mar 21, 2018 | $2,600 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| Feb 22, 2018 | $2,600 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| Jun 7, 2018 | $2,600 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| Jan 15, 2018 | $2,600 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| Apr 26, 2018 | $2,600 | PRIMARY CARE - DISEASE STATE | Honoraria | HORIZON PHARMA PLC | |
| Sep 25, 2018 | $2,350 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Jul 31, 2018 | $2,350 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Apr 23, 2018 | $2,350 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Oct 9, 2018 | $2,350 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| May 1, 2018 | $2,350 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Nov 15, 2018 | $2,350 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Jan 31, 2018 | $2,250 | No Listed Product | Promotional Speaking/Other | ABBVIE, INC. | |
| Apr 4, 2018 | $2,220 | ENTYVIO | Promotional Speaking/Other | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Dec 3, 2018 | $2,000 | XELJANZ | Promotional Speaking/Other | PFIZER INC. | |
| Dec 12, 2018 | $2,000 | XELJANZ | Promotional Speaking/Other | PFIZER INC. | |
| Apr 20, 2018 | $2,000 | INFLECTRA | Promotional Speaking/Other | PFIZER INC. | |
| Dec 11, 2018 | $2,000 | XELJANZ | Promotional Speaking/Other | PFIZER INC. | |
| Dec 3, 2018 | $2,000 | XELJANZ | Promotional Speaking/Other | PFIZER INC. | |
| Jun 14, 2018 | $1,697 | STELARA REMICADE | Travel and Lodging | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Mar 7, 2018 | $1,575 | HUMIRA | Promotional Speaking/Other | ABBVIE, INC. | |
| Apr 12, 2018 | $1,500 | STELARA REMICADE | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Sep 27, 2018 | $1,434 | STELARA REMICADE | Travel and Lodging | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Oct 1, 2018 | $1,400 | XELJANZ | Consulting | PFIZER INC. | |
| May 9, 2018 | $1,393 | STELARA REMICADE | Travel and Lodging | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| May 1, 2018 | $1,233 | STELARA REMICADE | Travel and Lodging | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Jun 28, 2018 | $873 | STELARA REMICADE | Travel and Lodging | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Oct 11, 2018 | $798 | STELARA REMICADE | Travel and Lodging | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Feb 13, 2018 | $778 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Nov 6, 2018 | $750 | STELARA | Promotional Speaking/Other | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Jan 3, 2018 | $738 | INFLECTRA | Travel and Lodging | PFIZER INC. | |
| May 10, 2018 | $716 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Sep 12, 2018 | $694 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Jan 29, 2018 | $694 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Mar 14, 2018 | $670 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Mar 14, 2018 | $670 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Jul 24, 2018 | $647 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Dec 25, 2018 | $640 | XELJANZ | Travel and Lodging | PFIZER INC. | |
| Jun 2, 2018 | $614 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Jul 31, 2018 | $613 | STELARA REMICADE | Travel and Lodging | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Jan 29, 2018 | $579 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Feb 27, 2018 | $565 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Aug 10, 2018 | $549 | INFLECTRA | Travel and Lodging | PFIZER INC. | |
| Aug 29, 2018 | $542 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Feb 15, 2018 | $534 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Nov 19, 2018 | $512 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Jan 10, 2018 | $505 | INFLECTRA | Travel and Lodging | PFIZER INC. | |
| Feb 2, 2018 | $485 | STELARA | Travel and Lodging | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Dec 12, 2018 | $484 | XELJANZ | Travel and Lodging | PFIZER INC. | |
| Jun 19, 2018 | $428 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Apr 12, 2018 | $415 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Dec 15, 2018 | $384 | XELJANZ | Travel and Lodging | PFIZER INC. | |
| Nov 19, 2018 | $358 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Jun 19, 2018 | $354 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Mar 9, 2018 | $350 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Sep 24, 2018 | $339 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Jan 30, 2018 | $334 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Sep 12, 2018 | $329 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Jul 24, 2018 | $317 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Sep 24, 2018 | $309 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Dec 3, 2018 | $287 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Sep 12, 2018 | $281 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Aug 29, 2018 | $276 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Jul 24, 2018 | $276 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| May 2, 2018 | $273 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Mar 29, 2018 | $273 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Aug 30, 2018 | $270 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Feb 15, 2018 | $261 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Feb 27, 2018 | $259 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Jun 26, 2018 | $258 | No Listed Product | Travel and Lodging | PFIZER INC. | |
| Nov 4, 2018 | $255 | XELJANZ | Travel and Lodging | PFIZER INC. | |
| May 2, 2018 | $252 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Jun 2, 2018 | $250 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Jun 2, 2018 | $232 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Jun 19, 2018 | $231 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Aug 30, 2018 | $225 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Dec 11, 2018 | $221 | XELJANZ | Travel and Lodging | PFIZER INC. | |
| Apr 12, 2018 | $209 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Oct 10, 2018 | $207 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Mar 14, 2018 | $207 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Mar 14, 2018 | $207 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Aug 29, 2018 | $205 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Aug 31, 2018 | $201 | INFLECTRA | Travel and Lodging | PFIZER INC. | |
| Feb 27, 2018 | $200 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Apr 11, 2018 | $197 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Mar 14, 2018 | $196 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Dec 11, 2018 | $183 | XELJANZ | Travel and Lodging | PFIZER INC. | |
| Feb 15, 2018 | $176 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Feb 26, 2018 | $173 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Sep 4, 2018 | $171 | INFLECTRA | Travel and Lodging | PFIZER INC. | |
| Nov 19, 2018 | $165 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Sep 24, 2018 | $164 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| May 10, 2018 | $160 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Oct 10, 2018 | $157 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Dec 3, 2018 | $155 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Jul 18, 2018 | $153 | No Listed Product | Travel and Lodging | PFIZER INC. | |
| Jan 11, 2018 | $145 | INFLECTRA | Travel and Lodging | PFIZER INC. | |
| Oct 10, 2018 | $145 | PRIMARY CARE - DISEASE STATE | Travel and Lodging | HORIZON PHARMA PLC | |
| Jul 17, 2018 | $145 | No Listed Product | Travel and Lodging | PFIZER INC. | |
| Dec 27, 2018 | $132 | XELJANZ | Travel and Lodging | PFIZER INC. | |
| Mar 29, 2018 | $130 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Mar 14, 2018 | $128 | ENTYVIO | Travel and Lodging | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Oct 11, 2018 | $125 | STELARA REMICADE | Food and Beverage | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Jun 19, 2018 | $125 | PRIMARY CARE - DISEASE STATE | Food and Beverage | HORIZON PHARMA PLC | |
| Feb 2, 2018 | $125 | STELARA | Food and Beverage | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Mar 29, 2018 | $125 | No Listed Product | Food and Beverage | ABBVIE, INC. | |
| Jun 14, 2018 | $124 | STELARA REMICADE | Food and Beverage | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Aug 31, 2018 | $123 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Mar 29, 2018 | $117 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Dec 11, 2018 | $114 | XELJANZ | Travel and Lodging | PFIZER INC. | |
| Apr 24, 2018 | $112 | STELARA REMICADE | Food and Beverage | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| May 2, 2018 | $112 | PRIMARY CARE - DISEASE STATE | Food and Beverage | HORIZON PHARMA PLC | |
| Jun 28, 2018 | $104 | STELARA REMICADE | Food and Beverage | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| May 9, 2018 | $104 | STELARA REMICADE | Food and Beverage | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Dec 27, 2018 | $103 | XELJANZ | Travel and Lodging | PFIZER INC. | |
| Jan 24, 2018 | $100 | No Listed Product | Food and Beverage | ABBVIE, INC. | |
| May 11, 2018 | $94 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| May 10, 2018 | $94 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| May 10, 2018 | $83 | No Listed Product | Food and Beverage | ABBVIE, INC. | |
| Aug 28, 2018 | $79 | INFLECTRA | Food and Beverage | PFIZER INC. | |
| May 1, 2018 | $71 | STELARA REMICADE | Food and Beverage | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Feb 27, 2018 | $52 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Feb 27, 2018 | $37 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Feb 3, 2018 | $33 | STELARA | Food and Beverage | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Feb 3, 2018 | $29 | STELARA | Food and Beverage | JANSSEN SCIENTIFIC AFFAIRS, LLC | |
| Mar 29, 2018 | $18 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Oct 11, 2018 | $16 | STELARA SIMPONI | Food and Beverage | JANSSEN BIOTECH, INC. | |
| Mar 29, 2018 | $15 | HUMIRA | Food and Beverage | ABBVIE, INC. | |
| Apr 12, 2018 | $13 | No Listed Product | Food and Beverage | ABBVIE, INC. | |
| Apr 12, 2018 | $5 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Mar 29, 2018 | $5 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| Aug 30, 2018 | $4 | HUMIRA | Travel and Lodging | ABBVIE, INC. | |
| May 10, 2018 | $1 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Aug 30, 2018 | $1 | No Listed Product | Travel and Lodging | ABBVIE, INC. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.